Supreme Court Weighs If Bayer’s Roundup Must Warn About Cancer Risks Amid EPA Oversight

The Supreme Court is poised to decide whether Bayer’s Roundup, the nation’s most widely used herbicide, must carry cancer warnings under state law despite federal approval by the Environmental Protection Agency (EPA). This case strikes at the heart of regulatory accountability and corporate responsibility, with more than 100,000 plaintiffs alleging that glyphosate, Roundup’s active ingredient, causes cancer.

The legal battle stems from John Durnell, who sued Monsanto (now owned by Bayer) after developing non-Hodgkin lymphoma following decades of exposure to Roundup. A Missouri jury found Monsanto liable for failing to warn users about cancer risks and awarded Durnell $1.25 million in damages. Monsanto has appealed, arguing that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state laws requiring additional warnings because the EPA approved Roundup’s label.

At issue is whether EPA’s pesticide labeling approval overrides state consumer protection laws designed to ensure adequate warnings. FIFRA mandates that pesticides cannot be “misbranded” and restricts states from imposing labeling requirements beyond federal standards. Monsanto claims this federal oversight should block state lawsuits, while Durnell’s side insists states must be able to respond to emerging scientific evidence about glyphosate’s dangers.

During oral arguments, justices seemed split. Justice Ketanji Brown Jackson questioned whether EPA approval should prevent states from acting on new research raising safety concerns. Justice Brett Kavanaugh expressed concern about a patchwork of state regulations undermining federal uniformity. This tension highlights a broader debate over federal agencies’ power and states’ role in protecting public health.

The stakes extend beyond legal technicalities. Glyphosate is sprayed on roughly 300 million acres of U.S. farmland annually—more than 280 million pounds each year. A 2021 EPA biological evaluation found that glyphosate likely harms over 1,600 endangered species, signaling widespread environmental damage. Farmworkers face especially high exposure risks, raising urgent civil rights and health equity issues.

Critics argue the EPA has repeatedly failed to label pesticides as carcinogens even when its own assessments indicate cancer risks. Environmental groups have challenged the EPA’s 2020 clearance of Roundup, with a federal appeals court overturning that decision in 2022. Experts warn that loopholes and inadequate oversight in pesticide regulation allow dangerous chemicals to remain on the market without proper warnings.

This Supreme Court case is more than a fight over one herbicide. It’s about whether federal agencies like the EPA will be allowed to rubber-stamp corporate interests at the expense of public health and environmental safety. The justices’ ruling will send a clear message on who holds power to protect Americans from toxic chemicals—corporations, federal regulators, or state governments fighting for their citizens.

As millions continue to be exposed to glyphosate, the Court’s decision will determine if victims can seek justice or remain silenced by bureaucratic shield. This is accountability in the balance—and we’ll be watching.